Single modality radical radiotherapy is an acceptable alternative for the older patient with squamous cell carcinoma of the oesophagus.
cancer
chemotherapy
oesophageal cancer
radiation therapy
Journal
BMJ open gastroenterology
ISSN: 2054-4774
Titre abrégé: BMJ Open Gastroenterol
Pays: England
ID NLM: 101660690
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
09
09
2020
revised:
01
12
2020
accepted:
20
12
2020
entrez:
28
1
2021
pubmed:
29
1
2021
medline:
25
11
2021
Statut:
ppublish
Résumé
Oesophageal cancer remains a common cause of cancer mortality worldwide. Increasingly, oncology centres are treating an older population and comorbidities may preclude multimodality treatment with chemoradiotherapy (CRT). We review outcomes of radical radiotherapy (RT) in an older population treating squamous cell carcinoma (SCC) oesophagus. Patients over 65 years receiving RT for SCC oesophagus between 2013 and 2016 in the West of Scotland were identified. Kaplan-Meier and Cox-regression analysis were used to compare overall survival (OS) between patients treated with radical RT and radical CRT. There were 83 patients over 65 years treated with either RT (n=21) or CRT (n=62). There was no significant difference in median OS between CRT versus RT (26.8 months vs 28.5 months, p=0.92). All patients receiving RT completed their treatment whereas 11% of CRT patients did not complete treatment. Survival in this non-trial older patient group managed with CRT is comparable to that reported in previous trials. RT shows better than expected outcomes which may reflect developments in RT technique. This review supports RT as an alternative in older patients, unfit for concurrent treatment.
Sections du résumé
BACKGROUND
Oesophageal cancer remains a common cause of cancer mortality worldwide. Increasingly, oncology centres are treating an older population and comorbidities may preclude multimodality treatment with chemoradiotherapy (CRT). We review outcomes of radical radiotherapy (RT) in an older population treating squamous cell carcinoma (SCC) oesophagus.
METHODS
Patients over 65 years receiving RT for SCC oesophagus between 2013 and 2016 in the West of Scotland were identified. Kaplan-Meier and Cox-regression analysis were used to compare overall survival (OS) between patients treated with radical RT and radical CRT.
RESULTS
There were 83 patients over 65 years treated with either RT (n=21) or CRT (n=62). There was no significant difference in median OS between CRT versus RT (26.8 months vs 28.5 months, p=0.92). All patients receiving RT completed their treatment whereas 11% of CRT patients did not complete treatment.
CONCLUSION
Survival in this non-trial older patient group managed with CRT is comparable to that reported in previous trials. RT shows better than expected outcomes which may reflect developments in RT technique. This review supports RT as an alternative in older patients, unfit for concurrent treatment.
Identifiants
pubmed: 33504498
pii: bmjgast-2020-000492
doi: 10.1136/bmjgast-2020-000492
pmc: PMC7843319
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
J Natl Cancer Inst. 2012 Aug 8;104(15):1133-63
pubmed: 22851269
Clin Oncol (R Coll Radiol). 2018 Oct;30(10):650-657
pubmed: 30057002
J Clin Oncol. 2007 May 1;25(13):1705-12
pubmed: 17470862
J Clin Oncol. 1990 Aug;8(8):1402-7
pubmed: 2166143
Ann Oncol. 2014 Jan;25(1):283-90
pubmed: 24356640
J Natl Cancer Inst. 2005 Jan 19;97(2):142-6
pubmed: 15657344
Ann Oncol. 2015 Feb;26(2):288-300
pubmed: 24936581
Int J Radiat Oncol Biol Phys. 1998 Oct 1;42(3):469-78
pubmed: 9806503
PLoS One. 2012;7(12):e52457
pubmed: 23300677
BMC Cancer. 2011 Oct 28;11:466
pubmed: 22035459
Clin Oncol (R Coll Radiol). 2017 Nov;29(11):760-766
pubmed: 28818538
Cancer Manag Res. 2016 Apr 22;8:39-44
pubmed: 27217796
Clin Oncol (R Coll Radiol). 2019 Jun;31(6):356-364
pubmed: 30737068
J Gastrointest Oncol. 2012 Dec;3(4):322-5
pubmed: 23205308
Br J Cancer. 2018 May;118(10):1391-1398
pubmed: 29563637
N Engl J Med. 1992 Jun 11;326(24):1593-8
pubmed: 1584260
Lancet. 2017 Nov 25;390(10110):2383-2396
pubmed: 28648400
J Clin Oncol. 2007 Apr 1;25(10):1160-8
pubmed: 17401004
Trans Am Clin Climatol Assoc. 2006;117:147-55; discussion 155-6
pubmed: 18528470
J Radiat Res. 2015 Jul;56(4):742-9
pubmed: 25907360
Lancet Oncol. 2013 Jun;14(7):627-37
pubmed: 23623280
Gut. 2015 Mar;64(3):381-7
pubmed: 25320104
J Gastrointest Oncol. 2016 Apr;7(2):166-72
pubmed: 27034782
Int J Radiat Oncol Biol Phys. 2019 Oct 1;105(2):329-337
pubmed: 31299242
J Clin Oncol. 2011 Apr 1;29(10):1290-6
pubmed: 21357782
Ann Thorac Surg. 2018 May;105(5):1516-1522
pubmed: 29409986
Radiother Oncol. 1998 Jul;48(1):15-21
pubmed: 9756167
Am J Med. 1988 Aug;85(2):194-6
pubmed: 2840825
Radiother Oncol. 2009 Jul;92(1):4-14
pubmed: 19446902
Clin Oncol (R Coll Radiol). 2020 Sep;32(9):553-561
pubmed: 32684503